HLA-Haploidentical Bone Marrow Transplantation (BMT) for High Risk Hematologic Malignancies Using Myeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide (Q127075864)
scholarly article
Language:
Current Data About HLA-Haploidentical Bone Marrow Transplantation (BMT) for High Risk Hematologic Malignancies Using Myeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
(P31) (Q13442814)
(P248)

(P304) 2362-2362
(P248)

(P407) (Q1860)
(P248)

(P433) 21
(P248)

(P478) 116
(P248)

(P577) Friday, November 19, 2010
(P248)

(P953) https://ashpublications.org/blood/article/116/21/2362/131917/HLAHaploidentical-Bone-Marrow-Transplantation-BMT
(P248)

(P1433) (Q885070)
(P248)

(P1476) "HLA-Haploidentical Bone Marrow Transplantation (BMT) for High Risk Hematologic Malignancies Using Myeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide" (language: en)
(P248)

(P2093) Heather Symons
(P1545) 1
(P248)

Allen R. Chen
(P1545) 2
(P248)

M. Sue Leffell
(P1545) 3
(P248)

Marianna Zahurak
(P1545) 4
(P248)

Kathy Schultz
(P1545) 5
(P248)

Heather Karaszkiewicz
(P1545) 6
(P248)

Leo Luznik
(P1545) 7
(P248)

Javier Bolanos Meade
(P1545) 8
(P248)

Yvette L. Kasamon
(P1545) 9
(P248)

Lode J. Swinnen
(P1545) 10
(P248)

Douglas Edward Gladstone
(P1545) 11
(P248)

Richard J. Jones
(P1545) 12
(P248)

Ephraim Fuchs
(P1545) 13
(P248)

other details
description scholarly article

External Links
(P356) 10.1182/BLOOD.V116.21.2362.2362